Home › Funds › Commodore Capital LP › VTGN

Commodore Capital LP position in VTGN

VISTAGEN THERAPEUTICS INC · Health Care

Commodore Capital LP reported holding 2,788,620 shares of VTGN (VISTAGEN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$630K, representing 0.04% of its reported portfolio and ranking #33 among its reported holdings. Commodore Capital LP has disclosed VTGN holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.79M sh
Reported value held$630.23K
Portfolio Weight0.04%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Commodore Capital LP's VTGN position evolved

Commodore Capital LP first disclosed a stake in VTGN in Q3 2023 at 1,575,000 shares (US$8.3M). The position peaked in Q1 2024 at 1,575,000 shares, worth US$8.3M. Across 10 filings, Commodore Capital LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,788,620 shares valued at US$630K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.57M $8.25M New
Q4 2023 1.57M $8.10M Hold
Q1 2024 1.57M $8.32M Hold
Q2 2024 1.57M $5.48M Hold
Q3 2024 1.57M $4.74M Hold
Q4 2024 1.57M $4.65M Hold
Q1 2025 1.57M $3.94M Hold
Q2 2025 1.57M $3.15M Hold
Q3 2025 1.57M $5.59M Hold
Q2 2026 2.79M $630.23K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VTGN and 13F data

VTGN (VISTAGEN THERAPEUTICS INC) is a Health Care company. 8 other funds we track also report a position in VTGN — the largest reported positions include LUMINUS MANAGEMENT LLC (US$91K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VTGN

All VTGN fund holders →

FAQ

How long has Commodore Capital LP held VTGN?

Commodore Capital LP has disclosed VTGN holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is Commodore Capital LP's current position in VTGN?

As of Q2 2026, Commodore Capital LP holds 2.79M shares of VTGN (VISTAGEN THERAPEUTICS INC), valued at $630.23K, representing 0.04% of its reported portfolio and ranking #33.

Has Commodore Capital LP been buying or selling VTGN?

In the latest 13F filing (Q2 2026), Commodore Capital LP newly opened its position in VTGN. The position peaked in Q1 2024 at 1.57M shares.

Which other funds hold VTGN?

Other major institutional holders of VTGN include LUMINUS MANAGEMENT LLC, among 8 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.